Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds

The data is a crucial step toward the two-shot coronavirus regimen vaccine becoming available for children, perhaps close to Halloween.

Read the full article here

Related Articles